Patents by Inventor Vadim Iourgenko

Vadim Iourgenko has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Organic Compounds
    Publication number: 20100316573
    Abstract: A method to predict which patients will respond to a IAP inhibiting compound comprising: a) administering an IAP inhibitor compound to a patient, and b) measuring TNF-? or IL-? levels.
    Type: Application
    Filed: October 17, 2007
    Publication date: December 16, 2010
    Inventors: Larry Alexander Gaither, Vadim Iourgenko, Mark Aron Labow, Dale Alan Porter, Christopher Sean Straub, Yao Yao, Leigh Zawel
  • Interleukin-1 related gene and protein
    Patent number: 7374911
    Abstract: Disclosed in an interleukin-1 related gene and gene product. In particular, the invention relates to a protein that is highly homologous to known interleukin-1 cytokines, nucleic acid molecules that encode such a protein, antibodies that recognize the protein, and methods for diagnosing conditions related to host inflammatory and immune responses.
    Type: Grant
    Filed: December 20, 2001
    Date of Patent: May 20, 2008
    Inventors: Mark A. Labow, Vadim Iourgenko
  • Interleukin-1 Related Gene and Protein
    Publication number: 20080045699
    Abstract: Disclosed is an interleukin-1 related gene and gene product. In particular, the invention relates to a protein that is highly homologous to known interleukin-1 cytokines, nucleic acid molecules that encode such a protein, antibodies that recognize the protein, and methods for diagnosing conditions related to host inflammatory and immune responses.
    Type: Application
    Filed: July 12, 2007
    Publication date: February 21, 2008
    Inventors: Mark Labow, Vadim Iourgenko
  • Cyclic amp response element activator proteins and uses related thereto
    Publication number: 20070036810
    Abstract: The invention discloses newly identified cyclic AMP response element activator proteins (CREAP proteins). It is contemplated herein that said proteins are suitable drug targets for the development of new therapeutics to prevent, treat or ameliorate pathological conditions related to abnormal activation of CRE-dependent gene expression or abnormal activation of chemokines. The invention relates to methods to prevent, treat or ameliorate said pathological conditions and pharmaceutical compositions therefor comprising modulators with inhibitory effect on CREAP protein activity and/or CREAP gene expression. The invention also relates to methods to identify compounds with therapeutic usefulness to treat said pathological conditions, comprising identifying compounds that can inhibit CREAP protein activity and/or CREAP gene expression.
    Type: Application
    Filed: March 25, 2004
    Publication date: February 15, 2007
    Inventors: Vadim Iourgenko, Mark Labow, Chuanzheng Song, Wenjun Zhang, Jian Zhu
  • Interleukin-1 related gene and protein
    Publication number: 20040241807
    Abstract: Disclosed in an interleukin-1 related gene and gene product. In particular, the invention relates to a protein that is highly homologous to known interleukin-1 cytokines, nucleic acid molecules that encode such a protein, antibodies that recognize the protein, and methods for diagnosing conditions related to host inflammatory and immune responses.
    Type: Application
    Filed: July 10, 2003
    Publication date: December 2, 2004
    Inventors: Mark A. Labow, Vadim Iourgenko